1.Opportunities and Challenges for the Rapid Development of FLASH Radiotherapy in China
Hui LUO ; Chengliang YANG ; Hong GE
China Cancer 2025;34(4):326-330
In recent years,FLASH radiotherapy(FLASH-RT),as a cutting-edge radiotherapy technology,has developed rapidly in basic research and clinical trials.FLASH-RT can deliver ultra-high dose rate(average dose rate≥40 Gy/s,instantaneous dose rate≥100 Gy/s)irradia-tion in a very short time(usually≤500 ms).Under the premise of maintaining equivalent tumor control rates,the normal tissue injury is less than that of conventional irradiation at the same dose,that is known as the FLASH effect.FLASH-RT has unique advantages and is currently the frontier field of radiation oncology.The research and development of FLASH-RT have progressed rapidly in China,this paper elucidated the new challenges and opportunities of FLASH-RT in China.
2.Incidence,Mortality and Disease Burden of Malignant Tu-mors in Cancer Registration Areas of Hubei Province in 2020
Shuang YAO ; Jiyu TUO ; Yu QIN ; Yafen XIA ; Min ZHANG
China Cancer 2025;34(4):255-263
[Purpose]To analyze the prevalence and disease burden of malignant tumors in cancer registration areas of Hubei Province in 2020.[Methods]The incidence and mortality data of ma-lignant tumors in cancer registration areas in Hubei Province in 2020 were collected,and the data were quality controlled according to the quality evaluation standards and methods formulated by the National Cancer Center.The data from 24 registries met the inclusion criteria.Using descrip-tive epidemiological methods to calculate incidence/mortality rate,age-specific incidence/mortality rate,standardized incidence/mortality rate by Chinese standard population(ASRC),standardized incidence/mortality rate by world standard population(ASRW).Disability-adjusted life years(DALY)and DALY rates were calculated using formulas provided by the World Health Organization to as-sess the disease burden of malignant tumors.[Results]In 2020,the crude incidence of malignant tumors in cancer registration areas of Hubei Province was 311.36/105,the ASRC was 184.14/105,the ASRW was 197.37/105,and the cumulative rate of 0~74 years old was 20.52%.The age-spe-cific incidence of malignant tumors in the province and rural areas reached its peak in the age group of 75~79 years old,while in urban areas it reached its peak in the age group of 80~84 years old.In 2020,the crude mortality rate of malignant tumors in cancer registration areas of Hubei Province was 184.58/105,the ASRC was 96.91/105,the ASRW was 110.92/105,and the cumulative rate of 0~74 years old was 11.01%.The age-specific mortality rate of malignant tumors in the province and urban areas reached its peak in the age group of above 85 years old,while in rural areas it reached its peak in the age group of 80~84 years old.Lung cancer ranked first in the incidence and mortality of malignant tumors in the province.In the cancer registration area of Hubei Province,the DALY of malignant tumors in 2020 was 641 497 person-years,and the DALY rate was 28.6‰.[Conclusion]Common cancers such as lung cancer,female breast cancer and upper digestive tract cancer have a great impact on the incidence,mortality and disease burden of malignant tumors in Hubei Province.Targeted cancer screening and early diagnosis and treatment are the most effective means to improve social and economic benefits.
3.Analysis of the Epidemic Characteristics of Lung Cancer in 2020 and the Trend from 2012 to 2020 in Hubei Province
Yu QIN ; Shuang YAO ; Jiyu TUO ; Yafen XIA ; Min ZHANG
China Cancer 2025;34(4):264-271
[Purpose]To analyze the epidemiological characteristics of lung cancer in 2020 and the trend from 2012 to 2020 in Hubei Province.[Methods]Qualified lung cancer registry data reported by 24 cancer registries in Hubei Province was utilized to estimate the number of new lung cancer cases and deaths.Incidence/mortality rate,age-specific incidence/mortality rate,age-standardized incidence/mortality rate by Chinese standard population(ASIRC and ASMRC)and by world stan-dard population(ASIRW and ASMRW),cumulative rate of 0~74 years old and other indicators of lung cancer in urban and rural areas,different sex,age groups in 2020 were calculated.Annual percentage change(APC),average annual percentage change(AAPC)and 95%confidence interval(CI)were calculated to analyze the trends of incidence and mortality of lung cancer in cancer regi-stration areas of Hubei Province from 2012 to 2020.[Results]In 2020,the estimated number of new lung cancer cases in Hubei Province was 41 531,accounting for 23.17%of all new cancer cases.The incidence rate was 72.13/105,with the ASIRC of 38.19/105 and ASIRW of 42.75/105 respectively.The cumulative incidence rate of 0~74 years old was 4.82%.The estimated number of lung cancer deaths in Hubei Province in 2020 was 31 374,accounting for 29.52%of all cancer deaths.The mortality rate was 54.49/105,with the ASMRC of 27.66/105 and ASMRW of 31.95/105,respectively.The cumulative mortality(0~74 years old)was 3.36%.The incidence of lung cancer was higher in urban areas than that in rural areas,and higher in men than that in women.The in-cidence and mortality of lung cancer increased with age,and reaching the peak in the age groups of 75~79 and 80~85 years old respectively.From 2012 to 2020,the overall trend of crude inci-dence and mortality of lung cancer in Hubei Province was stable.The ASIRC and ASMRC showed a slow decline during 2012-2020,with the AAPCs of-0.51%(95%CI:-1.06%~-0.02%)and-1.84%(95%CI:-2.65%~-0.53%),respectively.The ASIRC showed a slow decline(APC=-1.76%,95%CI:-3.30%~-1.03%)during 2012-2018 and increase trend(APC=3.33%,95%CI:0.61%~5.02%)during 2018-2020,respectively,while ASMRC showed a significant decrease trend(APC=-3.00%,95%CI:-6.58%~-1.13%)during 2016-2020.[Conclusion]The incidence and mortality levels of lung cancer in Hubei Province were relatively high,resulted in a heavy disease burden and no significant downward trend.In the future,we should continue to strengthen the compre-hensive prevention and treatment of lung cancer,and promote lung cancer screening and early diagno-sis and treatment for target populations vigorously,especially in rural areas.
4.Analysis of Opportunistic Screening Results for Upper Gastrointestinal Cancer in Hubei Province from 2022 to 2023
Jiyu TUO ; Shuang YAO ; Yu QIN ; Yafen XIA ; Fandi MENG ; Min ZHANG
China Cancer 2025;34(4):272-278
[Purpose]To analyze the opportunistic screening results of upper gastrointestinal can-cer in Hubei Province from 2022 to 2023.[Methods]The data of upper gastrointestinal cancer opportunistic screening program in Hubei Province from January 1,2022 to December 31,2023 were summarized.The biopsy rate,positive lesion detection rate and early diagnosis rate were ana-lyzed.The differences in rates between/among different sexes,age groups and regions were com-pared by x2 test,trend x2 test.[Results]A total of 372 507 people were included in the oppor-tunistic screening of upper gastrointestinal cancer from 2022 to 2023.Among them,100 379 in-dividuals underwent biopsy histopathological examination,with a biopsy rate of 26.95%.A total of 4 678 positive cases(high-grade intraepithelial neoplasia,early-stage cancer and advanced can-cer)were detected in the opportunistic screening,with a positive lesion detection rate of 1.26%.The detection rates of positive lesion in the esophagus,cardia and stomach were 0.61%,0.07%and 0.58%,respectively.There were 721 cases of early upper gastrointestinal cancer(high-grade intraepithelial neoplasia,early-stage cancer),representing an early diagnosis rate of 15.41%.The early diagnosis rates for the esophagus,cardia and stomach were 14.53%,11.96%and 16.89%,respectively.[Conclusions]The implementation of opportunistic screening for upper gastrointesti-nal cancer is conducive to expanding the coverage of screening.It is necessary to strengthen stan-dardized and homogeneous training and complete high-quality endoscopic examination to improve the detection rate and early diagnosis rate of opportunistic screening program for upper gastroin-testinal cancer.
5.Cancer Incidence and Mortality in Liaoning Cancer Regi-stration Areas from 2016 to 2020 and Trends from 2006 to 2020
Huijuan MU ; Yanxia LI ; Xiang MA ; Jun NA ; Liya YU ; Jiang TIAN ; Li LIU
China Cancer 2025;34(4):279-289
[Purpose]To analyze cancer incidence and mortality in Liaoning cancer registration areas from 2016 to 2020 and the trends from 2006 to 2020.[Methods]Cancer data in cancer registra-tion areas in Liaoning Province from 2016 to 2020 were collected.The incidence and mortality,age-standardized rate,cumulative rate(0~74 years old),and age-specific rate were calculated.Age-standardized incidence and mortality rate were calculated by the Chinese standard popula-tion(ASIRC,ASMRC)and Segi world standard population(ASIRW,ASMRW).Joinpoint software was applied to analyze the trends of incidence and mortality.[Results]From 2016 to 2020,the crude incidence rate of cancer in Liaoning cancer registration areas was 422.30/105,the ASIRC and ASIRW were 215.67/105 and 209.52/105.The ASIRC was higher in urban areas(225.00/105)than that in rural areas(190.15/105),and higher in male(221.47/105)than that in female(213.03/105).The crude mortality rate was 254.22/105,the ASMRC and ASMRW were 113.26/105 and 112.91/105.The ASMRC in urban areas(113.12/105)was the same as that in rural areas(113.01/105),and higher in male(146.86/105)than that in female(83.46/105).The ASIRW of lung cancer was 46.13/105,and the ASMRW was 32.04/105,both ranking the first of all cancers.From 2006 to 2020,the crude incidence,ASIRC and ASIRW in urban areas showed an increasing trend(AAPC=3.921%,t=16.222,P<0.05;AAPC=0.823%,t=2.409,P<0.05;AAPC=0.875%,t=2.933,P<0.05).The crude incidence,ASIRC and ASIRW in urban female were all rising(AAPC=4.151%,t=15.888,P<0.05;AAPC=1.597%,t=4.819,P<0.05;AAPC=1.514%,t=4.752,P<0.05).During the same period,the cancer mortality in urban areas showed an increasing trend(AAPC=3.175%,t=14.745,P<0.05),and the ASMRW showed a decreasing trend(AAPC=-0.908%,t=-2.273,P<0.05).The crude mor-tality of both men and women showed an increasing trend(AAPC=3.010%,t=6.032,P<0.05;AAPC=2.820%,t=5.921,P<0.05),while the crude mortality and ASMRW for female showed a significant downward trend(AAPC=-1.487%,t=-2.437,P<0.05;AAPC=-2.680%,t=-2.246,P<0.05).From 2016 to 2020,the crude incidence,ASIRC and ASIRW in rural areas showed no significant change;however,the crude incidence in male was increasing(AAPC=2.025%,t=3.853,P<0.05).In the same period,the crude mortality rate in rural areas increased(AAPC=3.577%,t=9.377,P<0.05),while there was no significant change in the ASMRC and ASMRW.The crude mortality of both men and women showed an increasing trend(AAPC=3.377%,t=10.615,P<0.05;AAPC=3.978%,t=7.245,P<0.05),while there was no significant change in ASMRC and ASMRW.[Conclusion]The cancer burden in Liaoning from 2016 to 2020 was higher than the average level in China,can-cer prevention and control should be further strengthened in the provice.
6.Trend of Incidence Rates of Gallbladder Cancer in Qi-dong City of Jiangsu Province from 1972 to 2021
Yuanyou XU ; Yonghui ZHANG ; Lulu DING ; Yongsheng CHEN ; Jun WANG ; Yongfeng YAN ; Jianguo CHEN ; Jian ZHU
China Cancer 2025;34(4):290-296
[Purpose]To analyze the trend of incidence rates of gallbladder cancer in Qidong City of Jiangsu Province from 1972 to 2021.[Methods]The incidence data of gallbladder cancer from 1972 to 2021 were collected from the Qidong Tumour Registry database,the crude incidence rate(CR),age-standardized rate by Chinese standard population(ASRC),age-standardized rate by world standard population(ASRW)of gallbladder cancer were calculated.Trend analysis was per-formed using Joinpoint 4.9.1.0 software to calculate the average annual percentage change(AAPC)of gallbladder cancer incidence rates,and time trend analysis was performed on the overall inci-dence rate by sex and age.[Results]A total of 1 369 cases of gallbladder cancer occurred in Qi-dong City from 1972 to 2021,accounting for 0.93%of all malignant tumors.The overall CR of gallbladder cancer was 2.44/105 in 50 years,ASRC was 0.88/105 and ASRW was 1.45/105.The truncated rate of 35~64 years old was 1.98/105,the cumulative incidence of gallbladder cancer at 0~74 years old was 0.16%,and the risk of cumulative incidence of gallbladder cancer was 0.16%.CR was slightly higher in women than that in men,but after standardization it was slightly higher in men than that in women.The sex ratio of CR,ASRC and ASRW was 0.89,1.07 and 1.06,respectively.With the increase of age,the incidence of gallbladder cancer was also increased.The age of onset was slightly increased in last 50 years.In last 50 years,there was an upward trend in the overall incidence of gallbladder cancer,the incidence both for men and women,and the inci-dence of each age group.[Conclusion]The incidence of gallbladder cancer in Qidong City has increased considerably during the past 50 years,and continuing attention should be paid to the prevention and treatment of gallbladder cancer especially for the key populations.
7.Analysis of Survival Rate of Breast Cancer from 1972 to 2019 and Prediction for Next 10 Years in Qidong City of Jiangsu Province
Junlei WANG ; Jun WANG ; Yongsheng CHEN ; Yuanyou XU ; Lulu DING ; Yonghui ZHANG ; Jianguo CHEN ; Jian ZHU ; Qichao NI
China Cancer 2025;34(4):304-310
[Purpose]To analyze the survival rate of breast cancer in Qidong City of Jiangsu Province from 1972 to 2019 and to predict the trend in the next 10 years.[Methods]The data of breast cancer collected from Qidong Cancer Registry from 1972 to 2019 were extracted.Observed survival rate(OSR),relative survival rate(RSR),age-adjusted relative survival(ARS)and average annual percentage change(AAPC)of breast cancer were calculated.ARIMA model was used to predict the trend of breast cancer survival rate.[Results]The 5-year RSR increased from 57.30%during 1972-1977 to 89.01%during 2014-2019,and the uptrend of RSR in the 8 periods was statistically significant(P<0.001).The 5-year ARS increased from 48.12%during 1972-1977 to 85.64%during 2014-2019 with an AAPC of 1.85%(t=10.113,P<0.001).The 5-year RSR during 1972-2019 for males was 85.22%,and for females was 74.51%.For females,the 5-year RSR in-creased from 56.44%during 1972-1977 to 88.93%during 2014-2019 with an AAPC of 1.29%(t=13.087,P<0.001),and the 5-year ARS increased from 46.14%during 1972-1977 to 85.23%during 2014-2019 with an AAPC of 1.90%(t=10.369,P<0.001).The 5-year RSR in the age groups of 25~34,35~44,45~54,55~64,65~74,and over 75 years old were 66.91%,74.69%,76.97%,75.52%,73.44%and 66.40%,respectively;the corresponding AAPCs of 5-RSR in above age groups were 1.02%(t=3.816,P=0.009),1.03%(t=4.936,P=0.003),1.23%(t=5.826,P=0.001),1.86%(t=5.997,P=0.001),2.13%(t=10.245,P<0.001),and 1.44%(t=6.405,P=0.001),respectively.ARIMA modeling of survival trend prediction showed that 5-RSR and 5-ARS for breast cancer will be ascended to 98.76%and 98.33%by 2028,respectively.[Conclusion]The overall survival rate of registered breast cancer cases in Qidong City has been greatly improved and will be further improved in the future,more attention should be paid to the prevention and treatment of breast cancer.
8.Trend of Non-Hodgkin's Lymphoma Incidence in Qidong City of Jiangsu Province from 1972 to 2021
Jun WANG ; Yongsheng CHEN ; Jian FAN ; Jian ZHU
China Cancer 2025;34(4):297-303
[Purpose]To analyze the trend of non-Hodgkin's lymphoma incidence in Qidong City of Jiangsu Province from 1972 to 2021.[Methods]The data of non-Hodgkin's lymphoma inci-dence collected from Qidong Cancer Registry from 1972 to 2021 were extracted.The crude inci-dence rate(CR),age-standardized rate by Chinese standard population(ASRC)and by world standard population(ASRW),truncated incidence rate(35~64 years old)and cumulative incidence rate(0~74 years old)were calculated.The age-period-cohort model was used to analyze the age,period,and cohort effects of incidence in non-Hodgkin's lymphoma.Joinpoint 4.9.1.0 software was used to calculate the average annual percentage change(AAPC)of non-Hodgkin's lymphoma incidence for trend analysis.[Results]There were a total of 2 681 cases of non-Hodgkin's lymphoma re-ported in Qidong from 1972 to 2021.The CR,ASRC,ASRW,the truncated incidence(35~64 years old)rate and cumulative incidence rate(0~74 years old)were 4.78/105,3.35/105,3.30/105,5.20/105 and 0.37%,respectively.There were 1 589 male cases,with CR,ASRC and ASRW of 5.75/105,4.19/105 and 4.14/105,respectively;and there were 1 092 female cases,with CR,AS-RC and ASRW of 3.84/105,2.60/105 and 2.54/105,respectively.Age-period-cohort analysis showed that the net drift value of non-Hodgkin's lymphoma incidence was 1.65(95%CI:1.19~2.11),and age,period and cohort effects were all important influencing factors of non-Hodgkin's lymphoma incidence rate(all P<0.05).The AAPCs for both sex,male and female of ASRC of non-Hodgkin's lymphoma in Qidong from 1972 to 2021 were 1.71%(95%CI:0.88%~2.54%,t=4.07),1.62%(95%CI:1.14%~2.11%,t=6.77),and 2.01%(95%CI:0.77%~3.26%,t=3.19),respectively,with a significant upward trend,and the differences were statistically significant(all P<0.01).[Conclusion]Non-Hodgkin's lymphoma in Qidong City shows an overall increasing trend in the age-standardized incidence over the past 50 years,with a higher incidence in male and in the el-derly population.
9.Weaving and Strengthening the Cancer Prevention and Control System,Creating a Model for Cancer Control in Hubei Province:Progress in Cancer Prevention and Control During the"323"Campaign in Hubei Province
Min ZHANG ; Jiyu TUO ; Shuang YAO ; Yu QIN ; Fandi MENG ; Yafen XIA ; Shaozhong WEI
China Cancer 2025;34(4):251-254
Malignant tumors,as chronic diseases that seriously affect human life and health,are one of the most serious public health problems worldwide in the 21st century.Hubei Province at-taches great importance to the prevention and control of chronic diseases such as cancer,and launched the"323"campaign in 2021.This paper reviews the progress of cancer prevention and control in the"323"campaign from 2021 to 2024 from the aspects of science popularization,tu-mor registration,cancer screening,standardized diagnosis and treatment,and grassroots capacity improvement,and explores the key points of cancer prevention and control work in Hubei Province in the next step.
10.Analysis of Screening Results of Cervical Cancer and Precancerous Lesions Among Women in Shihezi City of Xinjiang from 2021 to 2023
Yanqiu LI ; Xiaoju LI ; Yaling DU ; Bingyi ZHANG ; Xin SHI ; Sa LI ; Xiujuan JIN
China Cancer 2025;34(4):311-318
[Purpose]To analyze the results of cervical cancer screening among married women of 25~64 years old in Shihezi City from 2021 to 2023,and to explore the risk factors of cervical le-sions.[Methods]The results of cervical cancer screening among married women aged 25~64 years old in Shihezi City from 2021 to 2023 were retrospectively analyzed.The detection rates of common gynecological diseases,cervical cancer and precancerous lesions and human papillo-mavirus(HPV)infection by cervical cytology,colposcopy and cervical biopsy were analyzed.[Re-sults]The HPV infection(mainly single infection)rate was 10.74%.The common gynecological diseases were vaginitis,cervicitis and uterine leiomyoma.The detection rate of cervical cancer was 19.59/105,and the detection rate of cervical precancerous lesions was 308.52/105.Rural resi-dents,HPV 16/18 infection,genital warts were the risk factors for cervical lesions.[Conclusion]Female cervical lesions are significantly correlated with HPV 16/18 infection,genital condyloma acuminatum,particularly for rural residents,and preventive care,early screening and interven-tion should be strengthened for these populations.

Result Analysis
Print
Save
E-mail